$0.650
-0.037 (-5.63%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MBRX Prediction & Forecast by Similar Chart Analysis
Alphio's MBRX stock price prediction model matches the current Moleculin Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.64 (-1.90%). The 1-week path is $0.64 (-1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Moleculin Biotech Inc Stock?
Moleculin Biotech Inc (MBRX) is a good buy right now due to its recent positive clinical trial results showing complete remission rates of 43% for Annamycin, significantly outperforming standard chemotherapy's 12%. The stock has seen a 62.48% increase over the last 20 days, indicating strong momentum. However, the main risk is the company's negative cash flow, with a net income loss of $14.61 million in Q1 2026, which raises concerns about its financial sustainability without further funding.
MBRX stock price ended at $0.65 on Friday, after losing -5.63%
Moleculin Biotech Inc (MBRX) last closed at $0.6499, losing -5.63%. These facts feed the 1-day and 1-week MBRX price prediction above.
Analyst Consensus
Moleculin Biotech Inc (MBRX): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Moleculin Biotech Inc (MBRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MBRX, ranked by similarity.
Seasonality analysis for MBRX
Historically the probability of a positive August return for MBRX is 0.00%. January offers the highest probability of a positive month at 45.90%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MBRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.67 | $0.80 | $0.88 | +23.84% |
| Sep 2026 | $0.65 | $0.79 | $0.84 | +21.67% |
| Oct 2026 | $0.76 | $0.84 | $1.01 | +29.43% |
| Nov 2026 | $0.67 | $0.72 | $0.78 | +10.14% |
| Dec 2026 | $0.91 | $0.92 | $0.93 | +41.38% |
In 2026, Moleculin Biotech Inc (MBRX) is projected to range from $0.65 to $1.01.
Moleculin Biotech Inc 2026 monthly forecast
In Aug 2026, Moleculin Biotech Inc is projected to average $0.80, with a low of $0.67 and high of $0.88.
In Sep 2026, Moleculin Biotech Inc is projected to average $0.79, with a low of $0.65 and high of $0.84.
In Oct 2026, Moleculin Biotech Inc is projected to average $0.84, with a low of $0.76 and high of $1.01.
In Nov 2026, Moleculin Biotech Inc is projected to average $0.72, with a low of $0.67 and high of $0.78.
In Dec 2026, Moleculin Biotech Inc is projected to average $0.92, with a low of $0.91 and high of $0.93.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.